Market

GSK Q2 2025 presentation: Sales up 6%, EPS jumps 15% as Specialty Medicines lead growth

GSK Q2 2025 presentation: Sales up 6%, EPS jumps 15% as Specialty Medicines lead growth
Read More

Related Posts

Brown Forman stock price target raised to $32 by Evercore ISI

Brown Forman stock price target raised to $32 by Everco...

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Consumer spending points to strong GDP, but is momentum in the U.S. economy fading?

Consumer spending points to strong GDP, but is momentum...

Empire State Realty Trust declares Q4 dividend of $0.035 per share

Empire State Realty Trust declares Q4 dividend of $0.03...

US Treasury Secretary Bessent holds constructive call with China

US Treasury Secretary Bessent holds constructive call w...

Form 144 eToro Group Ltd For: 5 December

Form 144 eToro Group Ltd For: 5 December